8-K: MSP Recovery Faces Nasdaq Delisting for Equity, Bid Price

MSP Recovery, Inc. received additional delisting notices from Nasdaq due to non-compliance with minimum stockholders' equity and bid price requirements, with a hearing scheduled for December 11, 2025.

Summary

• Received a Staff Delisting Determination on October 22, 2025, for not meeting Nasdaq's minimum stockholders' equity requirement of $2.5 million, as reported in the 2024 Form 10-K.
• Did not meet alternative compliance standards, including a market value of listed securities of $35 million or net income from continuing operations of $500,000.
• Timely requested a review by a Nasdaq Hearings Panel on October 29, 2025, and submitted a required written submission on November 21, 2025.
• The hearing request has temporarily stayed the suspension of trading of the company's securities and the filing of Form 25-NSE.
• Received an additional staff determination on November 28, 2025, indicating non-compliance with Listing Rule 5550(a)(2) due to the bid price closing at less than $1 per share for 30 consecutive business days.
• This bid price non-compliance serves as an additional basis for delisting the company's securities from Nasdaq.
• The company will present its views on both deficiencies to the Panel at the December 11, 2025 hearing.
• There is no assurance that the Panel will grant the company's request for continued listing on the Nasdaq Capital Market.
• If the company's Common Stock ceases to be listed on Nasdaq, it expects to trade on the OTCQB Venture Market of the OTC Markets Group.

Sentiment

Score: 2

Explanation: The filing details multiple severe non-compliance issues with Nasdaq listing rules, including insufficient stockholders' equity and a sustained low bid price, leading to an ongoing delisting process. While a hearing is pending, the overall situation is highly negative, indicating significant operational or financial challenges and a high risk of delisting.

Positives

• The company's timely request for a hearing has temporarily stayed the suspension of trading of its securities and the filing of Form 25-NSE, pending the Panel's decision.

Negatives

• Non-compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million.
• Failure to meet alternative compliance standards, including a market value of listed securities of $35 million or net income of $500,000.
• Non-compliance with Nasdaq's bid price rule, with the stock closing below $1 per share for 30 consecutive business days.
• The additional staff determination regarding bid price non-compliance serves as an additional basis for delisting.
• There is no assurance that the Nasdaq Hearings Panel will grant the company's request for continued listing.

Risks

• Uncertainty regarding the Nasdaq Hearings Panel's decision on the company's request for continued listing on the Nasdaq Capital Market.
• Potential delisting of the company's common stock from the Nasdaq Capital Market.
• Risk that the company may not qualify for listing on the OTCQB Venture Market if its common shares are delisted from Nasdaq.
• General risks and uncertainties described in the company's most recent Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent Quarterly Reports on Form 10-Q.

Future Outlook

The company believes it has a reasonable basis for its forward-looking statements regarding its ability to maintain or regain compliance with Nasdaq's continued listing standards and its ability to qualify for listing on the OTCQB Venture Market if delisted. However, the company cautions that these statements are based on current facts and future projections, and there is no assurance that the Nasdaq Hearings Panel will grant the company's request for continued listing.

Management Comments

• "Although the Company believes that it has a reasonable basis for each forward-looking statement contained in this Current Report, the Company cautions that these statements are based on a combination of facts and factors currently known by it and its projections of the future, about which it cannot be certain."

Industry Context

This announcement highlights the stringent compliance requirements for companies listed on major U.S. exchanges like Nasdaq. Companies that fail to meet financial thresholds, such as minimum stockholders' equity, or operational metrics, like a sustained minimum bid price, face delisting. This situation is a common challenge for smaller or struggling public companies, impacting investor confidence and liquidity. The potential move to the OTCQB Venture Market is a typical path for companies delisted from major exchanges, offering a less stringent trading environment but often with reduced liquidity and investor visibility.

Comparison to Industry Standards

• Nasdaq's listing rules, including the $2.5 million minimum stockholders' equity and $1 minimum bid price, are standard for major U.S. exchanges. Companies like MSP Recovery that fall below these thresholds are subject to delisting procedures, similar to other companies that have faced compliance issues (e.g., Sorrento Therapeutics, which also faced delisting for bid price issues).
• The potential move to the OTCQB Venture Market is a common path for companies delisted from major exchanges, offering a less stringent trading environment but often with reduced liquidity and investor visibility compared to Nasdaq.

Stakeholder Impact

• Shareholders face potential delisting from Nasdaq, which could lead to reduced liquidity, lower stock price, and increased volatility if trading moves to the OTCQB Venture Market.
• Investors face increased uncertainty regarding the company's future listing status and financial stability due to ongoing compliance issues.

Next Steps

• The Nasdaq Hearings Panel will conduct its hearing on December 11, 2025.
• The company will present its views to the Panel regarding both the stockholders' equity and bid price deficiencies.
• If delisted from Nasdaq, the company expects its Common Stock to trade on the OTCQB Venture Market.

Key Dates

Recommendation

The company faces imminent delisting from Nasdaq due to multiple severe compliance failures, including insufficient stockholders' equity and a sustained sub-$1 bid price. While a hearing is scheduled, there is no assurance of continued listing. A move to the OTCQB Venture Market would likely result in significantly reduced liquidity and investor interest, further depressing the stock price. These fundamental issues indicate significant financial distress and regulatory risk, making the stock a strong sell for any investor.

Keywords

Nasdaq, delisting, stockholders' equity, bid price, compliance, 8-K, MSPR, corporate governance, regulatory, OTCQB